Member Info for Elartu

Dr Vicky Goh wins 'Most Influential Radiology Researcher' award.

https://www.auntminnieeurope.com/index.aspx?sec=sup&sub=pac&pag=dis&itemid=616915

My original post from 16th January follows.
_____________________________________________________________________________

I noticed this today.

https://www.auntminnieeurope.com/index.aspx?sec=nws&sub=rad&pag=dis&itemid=616801

And that Dr. Vicky Goh of King's College London is a finalist in the Most Influential Radiology Researcher category.

Her name was familiar so I checked it out and found the following quote from her...

"TexRAD provides unique tumor information, which in addition to standard morphological assessment, could improve therapeutic assessment in renal cancer treated with tyrosine kinase inhibitors. The preliminary results are encouraging for its use as a predictive biomarker in this clinical context."

... here.

https://www.sinc.co.uk/member-directory/texrad

And a paper from her and Balaji here.

https://www.researchgate.net/publication/51544630_Assessment_of_Response_to_Tyrosine_Kinase_Inhibitors_in_Metastatic_Renal_Cell_Cancer_CT_Texture_as_a_Predictive_Biomarker

Finally, in the original Aunt Minnie link I provided it states...

"One winner will be selected for each category by our expert panel. The winners will be announced in February, and the trophy presentations will take place at ECR 2019 in Vienna."

... which is where you will find Feedback Medical staff too.

https://www.youtube.com/watch?v=xJeWySiuq1I

Limits remain the same despite the 100k sale 5 minutes back.

Current on line limits:
Sell 375k at 1.135p
Buy 150 shares only (£6.72 worth) at 1.1485p

Just placing these links here because I find them interesting.

Towards Detecting High-Uptake Lesions from Lung CT Scans Using Deep Learning

http://discovery.ucl.ac.uk/10058534/1/Ganeshan_Towards%20Detecting%20High-Uptake%20Lesions%20from%20Lung%20CT%20Scans%20Using%20Deep%20Learning_AAM.pdf

https://lola11.grand-challenge.org/

My daughter was Raquel's hairdresser many years ago.

IQ-AI are likely very low on cash by now. Probably needs a placing in the very near future.

TexRAD research is between $25k and $50k depending on size of institution then 20% annual maintenance.

Cadran sales are more significant - around $150k plus annual maintenance per sale.

I like it more than if they'd passed it. I did not expect that resolution to be rejected. Think we have Tom Charlton to thank for that.

Well done Horsford, I'm sure you will get a decent profit out of those trades.

Hi Bob, that £1 million income comes from existing research sales, it certainly doesn't mean that it can't get higher from further research sales, new clinical sales, JV's, or CT scanner link ups. It is a conservative amount that can be extrapolated from figures in the public domain. What you and everyone else here are waiting for are the cherries on top of that. Patience.

Thanks for the link Bo. Good to hear that Alan Green agrees with me that income for this year will exceed £1 million (28 minute mark). I pointed this out when results indicated that at the back end of October so I'm surprised that it has taken almost 3 months more for someone else to come out with similar amount. Still good to have confirmation and it's better late than never.

I'll post the link on the competitor site if you don't mind as not much is going on over there these days.

Not really Adrian. Too much else to do at present. I have a sister who is not in the best of health and awaiting a significant operation, grandchildren who I like spending time with (spent today with my granddaughter and have only just waved goodbye and logged on here) and an obsession with Queen's Park Rangers that takes up a lot of my weekends. Just can't see me finding time to do more especially as I have around 75 unread books to get through before the grim reaper comes for me. However, I share whatever I find and you can freely use it in any way you want with my best wishes.

I noticed this today.

https://www.auntminnieeurope.com/index.aspx?sec=nws&sub=rad&pag=dis&itemid=616801

And that Dr. Vicky Goh of King's College London is a finalist in the Most Influential Radiology Researcher category.

Her name was familiar so I checked it out and found the following quote from her...

"TexRAD provides unique tumor information, which in addition to standard morphological assessment, could improve therapeutic assessment in renal cancer treated with tyrosine kinase inhibitors. The preliminary results are encouraging for its use as a predictive biomarker in this clinical context."

... here.

https://www.sinc.co.uk/member-directory/texrad

And a paper from her and Balaji here.

https://www.researchgate.net/publication/51544630_Assessment_of_Response_to_Tyrosine_Kinase_Inhibitors_in_Metastatic_Renal_Cell_Cancer_CT_Texture_as_a_Predictive_Biomarker

Finally, in the original Aunt Minnie link I provided it states...

"One winner will be selected for each category by our expert panel. The winners will be announced in February, and the trophy presentations will take place at ECR 2019 in Vienna."

... which is where you will find Feedback Medical staff too.

https://www.youtube.com/watch?v=xJeWySiuq1I

Hi Bob,
They have at least 285k more which they are offering at 1.4496p so we need another large trade before the price moves up. Cheaper than the placing price. I doubt it will stay that way much longer.

Evening Bob, when the MM's changed the spread just after 2pm I thought we might see another delayed purchase but it wasn't to be (so far). Let's see what tomorrow brings. I'm definitely hoping for some solid news around the last week of Feb / first week of March but that's mostly just me being optimistic.

BTW, remember way back we discovered TexRAD worked in pinpointing textural changes associated with Alzheimer's disease. Well, I've just read an article where AI can spot the disease up to 6 years before it can be seen by the humans. Would be good if TexRAD was still a contender in Alzheimer's diagnosis.

https://vaaju.com/franceeng/ai-can-detect-alzheimers-6-years-before-the-diagnosis-of-humans/

No idea Horsford, they don't appear to have picked many up in the market recently.

Someone likes the look of the destination.

04-Jan-19 14:28:30 1.35p 4,824,833 Buy*

We know we are on a journey but not sure of destination?
______________________________________________

A bit like QPR this season.
First time ever we've beaten Nottingham Forest at their ground - 34 failed attempts over 84 years.
First time we've made the 4th round of the FA Cup without need of a replay first since 1996.

Miracles are happening at QPR this year. No reason not to suppose we can't get a miracle here too.

Something magical when Spring is in the air perhaps.

Anyway, here's hoping the journey becomes more enjoyable soon.

https://www.youtube.com/watch?v=xJeWySiuq1I

January 2019 edition of Medicine journal.

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?

'DICOM images from CT examinations were imported to a secure offline server for radiomics analysis with commercially available software (TexRAD limited, UK).'

https://journals.lww.com/md-journal/Fulltext/2019/01040/Can_CT_radiomic_analysis_in_NSCLC_predict.53.aspx

Article also contains 13 citations referencing Balaji Ganeshan.

Happy New Year Bob. No guesses from me at present. Too many imponderables for now and I don't have the time or inclination to make a stab at them all. I find it hard to believe the company share price is only 1.3p but that's what a persistent malicious seller and a large placing dragged us down to in 2018. Now we are fully funded for 12 months and the seller has cleared off, we should end this year some way above the current price assuming we get a decent, regular news flow.